semaglutide from china price Novo Nordisk launches obesity drug Wegovy in Novo Nordisk sells hit weight-loss

Both use a gradual escalation schedule to minimize side effects

Switching from one to the other Switching between Wegovy and Mounjaro is a clinical decision, taken in clinic with a clear reason and a clear plan

For more detail on tirzepatide dosing for weight loss , the conversion chart lays out additional scenarios

Tirzepatide comes as two different medications: Zepbound, which is specifically FDA-approved for weight loss, and Mounjaro, which is authorized by the US FDA for people with type 2 diabetes

Hypoglycemia (low blood sugar) may also occur, particularly when combined with other diabetes medications that boost insulin production

Mounjaro received FDA approval in May 2022 for adults with type 2 diabetes